GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
73 hedge funds and large institutions have $19.2M invested in Aevi Genomic Medicine Inc in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
78% less capital invested
Capital invested by funds: $88.1M → $19.2M (-$68.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
73
Holding in Top 10
–
Calls
$2.74M
Puts
$549K
Top Buyers
| 1 | +$3.75M | |
| 2 | +$1.37M | |
| 3 | +$362K | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$288K |
| 5 |
RFCA
R&F Capital Advisors
New York
|
+$157K |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$8.91M | |
| 3 | -$3.94M | |
| 4 |
CC
Casdin Capital
New York
|
-$1.94M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.86M |